RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 107.25
+2.35 (2.24%)
At close: Jan 16, 2026
RemeGen Market Cap
RemeGen has a market cap or net worth of 55.63 billion as of January 16, 2026. Its market cap has increased by 300.70% in one year.
Market Cap
55.63B
Enterprise Value
56.61B
Revenue
2.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
107.25
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 55.63B, an increase of 95.03%. That is a compound annual growth rate of 13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 55.63B | 36.97% |
| Dec 31, 2025 | 40.62B | 208.65% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 420.14B |
| WuXi AppTec | 308.80B |
| Shenzhen Mindray Bio-Medical Electronics | 246.81B |
| Sichuan Biokin Pharmaceutical | 131.30B |
| Shanghai United Imaging Healthcare | 114.48B |
| Aier Eye Hospital Group | 108.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.67B |